A synergistic pharmaceutical product containing a combination of amantadine and selegiline for controlling the Parkinson's disease, depressions, narcolepsy and the organocerebral psychosyndrome.
PROCESS FOR PRODUCING A SYNERGISTIC COMBINATION OF AMANTADINE AND SELEGILINE